NCT06376097View on ClinicalTrials.gov

Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 19, 2023

Primary Completion Date

November 28, 2025

Study Completion Date

November 28, 2025

Conditions
Lung Cancer
Trial Locations (1)

18618-686

RECRUITING

Hospital das Clínicas da Faculdade de Medicina de Botucatu (HCFMB), Botucatu

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY